$4.42 -0.19 (%) Ariad Pharmaceuticals Inc - NASDAQ

Feb. 11, 2016 | 02:05 PM

Partner Headlines

  1. Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial

    Benzinga | Feb. 1, 2016 | 14:49PM EST
  2. Benzinga's Top Initiations

    Benzinga | Jan. 19, 2016 | 09:55AM EST
  3. ARIAD Elects of Alex Denner as Chairman of the Board of Directors

    Benzinga | Jan. 10, 2016 | 18:30PM EST
  4. Mid-Morning Market Update: Markets Open Lower; Dow Chemical And DuPont Announce Merger

    Benzinga | Dec. 11, 2015 | 10:12AM EST
  5. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 11, 2015 | 08:27AM EST
  6. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 15, 2015 | 08:20AM EST
  7. Mid-Morning Market Update: Markets Open Lower; BlackBerry To Acquire Good Technology For $425M

    Benzinga | Sep. 4, 2015 | 10:23AM EST
  8. Mid-Afternoon Market Update: NASDAQ Down 1.3%; Medicines Company Shares Gain Following Announcement Of Positive ALN-PCSsc Study Results

    Benzinga | Aug. 31, 2015 | 15:52PM EST
  9. Mid-Day Market Update: Crude Oil Surges 5.5%; ConforMIS Shares Tumble

    Benzinga | Aug. 31, 2015 | 13:05PM EST
  10. Morning Market Losers

    Benzinga | Aug. 31, 2015 | 09:54AM EST
  11. Benzinga's Top #PreMarket Losers

    Benzinga | Aug. 31, 2015 | 08:20AM EST
  12. Must Watch Stocks for August 31, 2015

    Benzinga | Aug. 31, 2015 | 05:19AM EST
  13. Benzinga's Weekend M&A Chatter

    Benzinga | Aug. 30, 2015 | 20:30PM EST
  14. Mid-Day Market Update: Tuesday's Top Shorted Stocks

    Benzinga | Aug. 18, 2015 | 14:28PM EST
  15. Michael Price Invests in 11 Companies in First Quarter

    GuruFocus | May. 19, 2015 | 18:17PM EST
  16. Morning Market Gainers

    Benzinga | Apr. 29, 2015 | 09:46AM EST
  17. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 29, 2015 | 08:15AM EST
  18. ARIAD Offers Updated Clinical Data for Brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer

    Benzinga | Apr. 17, 2015 | 07:37AM EST
  19. JMP Feeling Mostly Good On 4 Drug, Healthcare Stocks

    Benzinga | Feb. 21, 2015 | 14:21PM EST
  20. Technical Breakout In Ariad Pharmaceuticals

    Benzinga | Feb. 20, 2015 | 14:06PM EST
  21. Earnings Scheduled For February 19, 2015

    Benzinga | Feb. 19, 2015 | 04:47AM EST
  22. CNBC's Stock Pops & Drops From February 13

    Benzinga | Feb. 14, 2015 | 19:56PM EST
  23. Tuesday's Morning Movers: FXCM Takes Another Big Drop

    Benzinga | Jan. 20, 2015 | 09:44AM EST
  24. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  25. UPDATE: ARIAD 2015 Objectives and 2014 Preliminary Results

    Benzinga | Jan. 13, 2015 | 07:36AM EST
  26. Credit Suisse's 4 Healthcare Stocks To Avoid

    Benzinga | Jan. 11, 2015 | 13:15PM EST
  27. Tuesday's #PreMarket Movers: Neuroderm, Microsoft, Medbox, Civeo And More

    Benzinga | Dec. 30, 2014 | 09:17AM EST
  28. Tuesday's #PreMarket Movers: NQ Mobile, Cytokinetics, Walgreen And More

    Benzinga | Dec. 23, 2014 | 09:23AM EST
  29. Mid-Afternoon Market Update: Oxford Industries Drops On Downbeat Results; Office Depot Shares Spike Higher

    Benzinga | Dec. 11, 2014 | 15:59PM EST
  30. Mid-Day Market Update: Dow Jumps Over 200 Points; Staples Shares Surge On Confirmation Of Stake By Starboard Value

    Benzinga | Dec. 11, 2014 | 12:40PM EST
  31. Mid-Morning Market Update: Markets Surge; Lululemon Profit Beats Expectations

    Benzinga | Dec. 11, 2014 | 10:57AM EST
  32. Morning Market Losers

    Benzinga | Dec. 11, 2014 | 09:57AM EST
  33. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 11, 2014 | 08:28AM EST
  34. ARIAD Reports Follow-up Data from Phase 1, PACE Trials of Ponatinib for T315I Mutation

    Benzinga | Dec. 9, 2014 | 07:37AM EST
  35. ARIAD Reports Long-term Safety, Efficacy Data of Ponatinib from Phase 2 Pace Trial: 83% of CP-CML Patients Achieved Response

    Benzinga | Dec. 8, 2014 | 07:36AM EST
  36. Morning Market Movers

    Benzinga | Nov. 24, 2014 | 09:46AM EST
  37. Credit Suisse Expects New Pricing To Boost Sales For Ariad Pharmaceuticals

    Benzinga | Nov. 6, 2014 | 09:58AM EST
  38. Earnings Scheduled For November 5, 2014

    Benzinga | Nov. 5, 2014 | 05:05AM EST
  39. ARIAD Announces Recommendation For Iclusig By The Pharmacovigilance Risk Assessment Committee Of The European Medicines Agency

    Benzinga | Oct. 10, 2014 | 07:46AM EST
  40. Wayfair rises, Westport Innovations cuts 2014 forecast

    FoxBusiness | Oct. 6, 2014 | 08:30AM EST
  41. Markets Mixed; Constellation Brands Posts Downbeat Profit

    Benzinga | Oct. 2, 2014 | 10:38AM EST
  42. Morning Market Movers

    Benzinga | Oct. 2, 2014 | 09:44AM EST
  43. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 2, 2014 | 08:38AM EST
  44. ARIAD Offers Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer

    Benzinga | Sep. 29, 2014 | 07:36AM EST
  45. GNC, Southern Copper And Others Insiders Have Been Buying

    Benzinga | Aug. 25, 2014 | 13:34PM EST
  46. ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel

    Benzinga | Aug. 5, 2014 | 07:41AM EST
  47. Morning Market Movers

    Benzinga | Jul. 24, 2014 | 09:44AM EST
  48. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 24, 2014 | 08:08AM EST
  49. Benzinga's M&A Chatter for Wednesday July 23, 2014

    Benzinga | Jul. 23, 2014 | 18:48PM EST
  50. ARIAD Announces Continuation of Iclusig Review Related to Article 20 Procedure in Europe

    Benzinga | Jul. 14, 2014 | 07:36AM EST
Trading Center